Brief: Strides Pharma Science Says Receipt Of NCLT Approval For Creation Of Onesource
19/11/2024 11:16
Nov 19 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* RECEIPT OF NCLT APPROVAL FOR CREATION OF ONESOURCE
* FOLLOWING APPROVAL, ONESOURCE WILL ADVANCE TOWARDS LISTING
ITS
SHARES
Source text: ID:nNSE69gFWY
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees